Recent advances in melanoma research

被引:5
作者
Reed, Jon A.
Medrano, Estela E.
机构
[1] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Dermatol, Houston, TX 77030 USA
[3] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA
[4] Baylor Coll Med, Dept Mol Biol, Houston, TX 77030 USA
[5] Baylor Coll Med, Dept Cellular Biol, Houston, TX 77030 USA
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2006年 / 11卷
基金
日本学术振兴会;
关键词
melanoma; nevus; melanocyte; nevi B RAF; MIT F; cyclin E; HDAC inhibitors; senescence; review;
D O I
10.2741/2028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
At the end of the last decade, sporadic melanomas were still considered a genetic black box. Fortunately, in the last few years the box has been opened bringing to light melanoma-relevant oncogenes, aberrant signal transduction pathways, critical alterations in the melanoma cell cycle that go beyond p16(INK4a), and melanoma-microenvironment interactions that are essential for tumor progression. This review will discuss some of the latest findings in melanoma research including the critical role of the MAPK pathway in the genesis of melanoma and senescence of nevi, the paradoxical tumor suppressor and oncogenic activities of the transcription factor MITF, and the unexpected oncogenic activities of the low molecular weight forms of cyclin E.
引用
收藏
页码:3003 / 3013
页数:11
相关论文
共 115 条
[91]   Global histone modification patterns predict risk of prostate cancer recurrence [J].
Seligson, DB ;
Horvath, S ;
Shi, T ;
Yu, H ;
Tze, S ;
Grunstein, M ;
Kurdistani, SK .
NATURE, 2005, 435 (7046) :1262-1266
[92]   Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2′-deoxycytidine [J].
Sigalotti, L ;
Fratta, E ;
Coral, S ;
Tanzarella, S ;
Danielli, R ;
Colizzi, F ;
Fonsatti, E ;
Traversari, C ;
Altomonte, M ;
Maio, M .
CANCER RESEARCH, 2004, 64 (24) :9167-9171
[93]   A pivotal role for ERK in the oncogenic behaviour of malignant melanoma? [J].
Smalley, KSM .
INTERNATIONAL JOURNAL OF CANCER, 2003, 104 (05) :527-532
[94]   Melanocytes and the Microphthalmia transcription factor network [J].
Steingrímsson, E ;
Copeland, NG ;
Jenkins, NA .
ANNUAL REVIEW OF GENETICS, 2004, 38 :365-411
[95]   The heregulin/human epidermal growth factor receptor as a new growth factor system in melanoma with multiple ways of deregulation [J].
Stove, C ;
Stove, V ;
Derycke, L ;
Van Marck, V ;
Mareel, M ;
Bracke, M .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 121 (04) :802-812
[96]   Epigenetics and the environment [J].
Sutherland, JE ;
Costa, M .
EPIGENETICS IN CANCER PREVENTION: EARLY DETECTION AND RISK ASSESSMENT, 2003, 983 :151-160
[97]  
Sviderskaya EV, 2002, JNCI-J NATL CANCER I, V94, P446
[98]   Constitutive activation of the mitogen-activated protein kinase signaling pathway in acral melanomas [J].
Takata, M ;
Goto, Y ;
Ichii, N ;
Yamaura, M ;
Murata, H ;
Koga, H ;
Fujimoto, A ;
Saida, T .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (02) :318-322
[99]   Cutaneous melanoma [J].
Thompson, JF ;
Scolyer, RA ;
Kefford, RF .
LANCET, 2005, 365 (9460) :687-701
[100]   BRAF as a potential therapeutic target in melanoma and other malignancies [J].
Tuveson, DA ;
Weber, BL ;
Herlyn, M .
CANCER CELL, 2003, 4 (02) :95-98